Page last updated: 2024-12-05

2-methylphenanthrene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

2-Methylphenanthrene is a polycyclic aromatic hydrocarbon (PAH) that has been studied for its potential environmental and health effects. It is a component of coal tar and has been detected in contaminated soil and water. 2-Methylphenanthrene can be synthesized through various methods, including Friedel-Crafts alkylation of phenanthrene with methyl chloride. Research on 2-Methylphenanthrene focuses on its potential carcinogenicity, mutagenicity, and other toxicological effects. Studies have shown that it exhibits weak mutagenic activity in bacterial assays. Its importance lies in its potential contribution to environmental pollution and its impact on human health. Further research is needed to fully understand its long-term effects.'

Cross-References

ID SourceID
PubMed CID17321
CHEMBL ID1797288
MeSH IDM0284943

Synonyms (27)

Synonym
nsc-89276
nsc89276
2531-84-2
BIDD:GT0461
2-methyl-phenanthrene
2-methylphenanthrene
phenanthrene, 2-methyl-
inchi=1/c15h12/c1-11-6-9-15-13(10-11)8-7-12-4-2-3-5-14(12)15/h2-10h,1h
ccris 5482
einecs 219-791-0
nsc 89276
2-methyl phenanthrene
NCGC00248708-01
CHEMBL1797288
5iqj3j6pn0 ,
unii-5iqj3j6pn0
dtxcid505649
tox21_200567
dtxsid1025649 ,
NCGC00258121-01
cas-2531-84-2
AKOS024329378
A817784
FT-0600669
methyl phenanthrene, 2-
2-methylphenanthrene 10 microg/ml in cyclohexane
Q26840831
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (17)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency31.83490.007215.758889.3584AID1224835
RAR-related orphan receptor gammaMus musculus (house mouse)Potency30.73140.006038.004119,952.5996AID1159521; AID1159523
AR proteinHomo sapiens (human)Potency15.78630.000221.22318,912.5098AID1259243; AID1259247; AID743063
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency38.16530.001022.650876.6163AID1224838; AID1224839; AID1224893
progesterone receptorHomo sapiens (human)Potency27.38930.000417.946075.1148AID1346795
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency27.95290.003041.611522,387.1992AID1159552; AID1159553; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency8.22120.001530.607315,848.9004AID1224848; AID1224849; AID1259403
farnesoid X nuclear receptorHomo sapiens (human)Potency55.14940.375827.485161.6524AID743217
pregnane X nuclear receptorHomo sapiens (human)Potency54.64890.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency28.04530.000229.305416,493.5996AID1259244; AID1259248; AID743078; AID743079; AID743080; AID743091
aryl hydrocarbon receptorHomo sapiens (human)Potency64.95040.000723.06741,258.9301AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency6.87990.001723.839378.1014AID743083
thyroid stimulating hormone receptorHomo sapiens (human)Potency48.09410.001628.015177.1139AID1224895; AID1259385
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency55.149419.739145.978464.9432AID1159509
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency6.87990.000323.4451159.6830AID743065
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency24.41080.001557.789015,848.9004AID1259244
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency24.41080.001551.739315,848.9004AID1259244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID603957Octanol-water partition coefficient, log P of the compound2008European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
QSPR modeling of octanol/water partition coefficient for vitamins by optimal descriptors calculated with SMILES.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (14.29)18.7374
1990's2 (28.57)18.2507
2000's4 (57.14)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.25

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.25 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.69 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.25)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]